nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—VCAM1—RANKL/RANK Signaling Pathway—TNFRSF11A—Paget's disease of bone	0.027	0.12	CbGpPWpGaD
Carvedilol—GJA1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—BGLAP—Paget's disease of bone	0.0133	0.0589	CbGpPWpGaD
Carvedilol—VCAM1—RANKL/RANK Signaling Pathway—TNFRSF11B—Paget's disease of bone	0.0118	0.052	CbGpPWpGaD
Carvedilol—SELE—Glucocorticoid receptor regulatory network—BGLAP—Paget's disease of bone	0.0116	0.0514	CbGpPWpGaD
Carvedilol—VEGFA—NOTCH1 regulation of human endothelial cell calcification—ALPL—Paget's disease of bone	0.0111	0.0493	CbGpPWpGaD
Carvedilol—HIF1A—Notch-mediated HES/HEY network—BGLAP—Paget's disease of bone	0.0106	0.0469	CbGpPWpGaD
Carvedilol—SELE—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.00959	0.0424	CbGpPWpGaD
Carvedilol—VCAM1—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.00907	0.0401	CbGpPWpGaD
Carvedilol—VCAM1—Interferon gamma signaling—PML—Paget's disease of bone	0.00874	0.0387	CbGpPWpGaD
Carvedilol—HIF1A—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.00872	0.0386	CbGpPWpGaD
Carvedilol—VEGFA—Signaling events mediated by TCPTP—CSF1—Paget's disease of bone	0.00658	0.0291	CbGpPWpGaD
Carvedilol—KCNH2—Hematopoietic Stem Cell Differentiation—CSF1—Paget's disease of bone	0.00597	0.0264	CbGpPWpGaD
Carvedilol—VEGFA—Differentiation Pathway—CSF1—Paget's disease of bone	0.00569	0.0252	CbGpPWpGaD
Carvedilol—VCAM1—Interferon Signaling—NUP205—Paget's disease of bone	0.00483	0.0214	CbGpPWpGaD
Carvedilol—VEGFA—Integrins in angiogenesis—CSF1—Paget's disease of bone	0.00458	0.0203	CbGpPWpGaD
Carvedilol—VCAM1—Interferon Signaling—PML—Paget's disease of bone	0.00427	0.0189	CbGpPWpGaD
Carvedilol—HIF1A—Cellular responses to stress—VCP—Paget's disease of bone	0.00392	0.0173	CbGpPWpGaD
Carvedilol—GJA1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00392	0.0173	CbGpPWpGaD
Carvedilol—VEGFA—Endochondral Ossification—ALPL—Paget's disease of bone	0.00386	0.0171	CbGpPWpGaD
Carvedilol—GJA1—Myometrial Relaxation and Contraction Pathways—CALCA—Paget's disease of bone	0.00353	0.0156	CbGpPWpGaD
Carvedilol—VCAM1—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.00323	0.0143	CbGpPWpGaD
Carvedilol—ADRB1—Endothelin Pathways—CALCA—Paget's disease of bone	0.00301	0.0133	CbGpPWpGaD
Carvedilol—VCAM1—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.00285	0.0126	CbGpPWpGaD
Carvedilol—VCAM1—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.00275	0.0122	CbGpPWpGaD
Carvedilol—SELE—Hemostasis—INPP5D—Paget's disease of bone	0.0026	0.0115	CbGpPWpGaD
Carvedilol—VCAM1—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.00247	0.0109	CbGpPWpGaD
Carvedilol—ADRA1A—Endothelin Pathways—CALCA—Paget's disease of bone	0.00244	0.0108	CbGpPWpGaD
Carvedilol—Urinary tract infection—Risedronate—Paget's disease of bone	0.0023	0.00297	CcSEcCtD
Carvedilol—Discomfort—Etidronic acid—Paget's disease of bone	0.00228	0.00294	CcSEcCtD
Carvedilol—Flatulence—Alendronate—Paget's disease of bone	0.00227	0.00293	CcSEcCtD
Carvedilol—Bronchospasm—Zoledronate—Paget's disease of bone	0.00227	0.00293	CcSEcCtD
Carvedilol—Pneumonia—Pamidronate—Paget's disease of bone	0.00226	0.00292	CcSEcCtD
Carvedilol—Sweating increased—Zoledronate—Paget's disease of bone	0.00225	0.0029	CcSEcCtD
Carvedilol—Confusional state—Etidronic acid—Paget's disease of bone	0.00223	0.00288	CcSEcCtD
Carvedilol—Sinusitis—Risedronate—Paget's disease of bone	0.00222	0.00287	CcSEcCtD
Carvedilol—Muscle spasms—Alendronate—Paget's disease of bone	0.00222	0.00286	CcSEcCtD
Carvedilol—Renal failure—Pamidronate—Paget's disease of bone	0.00221	0.00286	CcSEcCtD
Carvedilol—Infection—Etidronic acid—Paget's disease of bone	0.00219	0.00283	CcSEcCtD
Carvedilol—Pancytopenia—Zoledronate—Paget's disease of bone	0.00219	0.00283	CcSEcCtD
Carvedilol—Urinary tract infection—Pamidronate—Paget's disease of bone	0.00219	0.00283	CcSEcCtD
Carvedilol—Haematuria—Pamidronate—Paget's disease of bone	0.00215	0.00277	CcSEcCtD
Carvedilol—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00214	0.00277	CcSEcCtD
Carvedilol—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00214	0.00276	CcSEcCtD
Carvedilol—Haemoglobin—Risedronate—Paget's disease of bone	0.00214	0.00276	CcSEcCtD
Carvedilol—Anaemia—Alendronate—Paget's disease of bone	0.00213	0.00275	CcSEcCtD
Carvedilol—Rhinitis—Risedronate—Paget's disease of bone	0.00213	0.00275	CcSEcCtD
Carvedilol—Pollakiuria—Zoledronate—Paget's disease of bone	0.00213	0.00275	CcSEcCtD
Carvedilol—Haemorrhage—Risedronate—Paget's disease of bone	0.00212	0.00275	CcSEcCtD
Carvedilol—Sinusitis—Pamidronate—Paget's disease of bone	0.00211	0.00273	CcSEcCtD
Carvedilol—Pharyngitis—Risedronate—Paget's disease of bone	0.00211	0.00272	CcSEcCtD
Carvedilol—Angioedema—Alendronate—Paget's disease of bone	0.00211	0.00272	CcSEcCtD
Carvedilol—Urinary tract disorder—Risedronate—Paget's disease of bone	0.0021	0.00271	CcSEcCtD
Carvedilol—Weight increased—Zoledronate—Paget's disease of bone	0.0021	0.00271	CcSEcCtD
Carvedilol—Oedema peripheral—Risedronate—Paget's disease of bone	0.00209	0.0027	CcSEcCtD
Carvedilol—Weight decreased—Zoledronate—Paget's disease of bone	0.00209	0.00269	CcSEcCtD
Carvedilol—Urethral disorder—Risedronate—Paget's disease of bone	0.00208	0.00269	CcSEcCtD
Carvedilol—Malaise—Alendronate—Paget's disease of bone	0.00208	0.00269	CcSEcCtD
Carvedilol—Vertigo—Alendronate—Paget's disease of bone	0.00207	0.00268	CcSEcCtD
Carvedilol—Depression—Zoledronate—Paget's disease of bone	0.00205	0.00265	CcSEcCtD
Carvedilol—Haemoglobin—Pamidronate—Paget's disease of bone	0.00203	0.00262	CcSEcCtD
Carvedilol—Rhinitis—Pamidronate—Paget's disease of bone	0.00202	0.00262	CcSEcCtD
Carvedilol—Renal failure—Zoledronate—Paget's disease of bone	0.00202	0.00261	CcSEcCtD
Carvedilol—Haemorrhage—Pamidronate—Paget's disease of bone	0.00202	0.00261	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00201	0.0026	CcSEcCtD
Carvedilol—Urinary tract infection—Zoledronate—Paget's disease of bone	0.002	0.00258	CcSEcCtD
Carvedilol—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00199	0.00258	CcSEcCtD
Carvedilol—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00198	0.00256	CcSEcCtD
Carvedilol—Tinnitus—Risedronate—Paget's disease of bone	0.00198	0.00256	CcSEcCtD
Carvedilol—Urethral disorder—Pamidronate—Paget's disease of bone	0.00198	0.00256	CcSEcCtD
Carvedilol—Myalgia—Alendronate—Paget's disease of bone	0.00196	0.00254	CcSEcCtD
Carvedilol—Chest pain—Alendronate—Paget's disease of bone	0.00196	0.00254	CcSEcCtD
Carvedilol—Haematuria—Zoledronate—Paget's disease of bone	0.00196	0.00253	CcSEcCtD
Carvedilol—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00194	0.00251	CcSEcCtD
Carvedilol—Discomfort—Alendronate—Paget's disease of bone	0.00194	0.00251	CcSEcCtD
Carvedilol—Angiopathy—Risedronate—Paget's disease of bone	0.00193	0.00249	CcSEcCtD
Carvedilol—Immune system disorder—Risedronate—Paget's disease of bone	0.00192	0.00248	CcSEcCtD
Carvedilol—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00191	0.00247	CcSEcCtD
Carvedilol—Constipation—Etidronic acid—Paget's disease of bone	0.00189	0.00244	CcSEcCtD
Carvedilol—Bradycardia—Zoledronate—Paget's disease of bone	0.00188	0.00243	CcSEcCtD
Carvedilol—Infection—Alendronate—Paget's disease of bone	0.00187	0.00241	CcSEcCtD
Carvedilol—Malnutrition—Risedronate—Paget's disease of bone	0.00185	0.00239	CcSEcCtD
Carvedilol—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00184	0.00237	CcSEcCtD
Carvedilol—Angiopathy—Pamidronate—Paget's disease of bone	0.00183	0.00237	CcSEcCtD
Carvedilol—Immune system disorder—Pamidronate—Paget's disease of bone	0.00182	0.00236	CcSEcCtD
Carvedilol—Flatulence—Risedronate—Paget's disease of bone	0.00182	0.00235	CcSEcCtD
Carvedilol—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00182	0.00235	CcSEcCtD
Carvedilol—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00182	0.00235	CcSEcCtD
Carvedilol—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00182	0.00235	CcSEcCtD
Carvedilol—Oedema peripheral—Zoledronate—Paget's disease of bone	0.00182	0.00235	CcSEcCtD
Carvedilol—Urethral disorder—Zoledronate—Paget's disease of bone	0.00181	0.00234	CcSEcCtD
Carvedilol—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00181	0.00233	CcSEcCtD
Carvedilol—Back pain—Risedronate—Paget's disease of bone	0.00179	0.00231	CcSEcCtD
Carvedilol—VEGFA—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.00179	0.0079	CbGpPWpGaD
Carvedilol—Alopecia—Pamidronate—Paget's disease of bone	0.00178	0.00231	CcSEcCtD
Carvedilol—Muscle spasms—Risedronate—Paget's disease of bone	0.00178	0.0023	CcSEcCtD
Carvedilol—ADRB3—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00176	0.00779	CbGpPWpGaD
Carvedilol—Malnutrition—Pamidronate—Paget's disease of bone	0.00176	0.00227	CcSEcCtD
Carvedilol—Urticaria—Etidronic acid—Paget's disease of bone	0.00175	0.00227	CcSEcCtD
Carvedilol—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00175	0.00226	CcSEcCtD
Carvedilol—Tension—Pamidronate—Paget's disease of bone	0.00173	0.00223	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00171	0.00221	CcSEcCtD
Carvedilol—Anaemia—Risedronate—Paget's disease of bone	0.00171	0.00221	CcSEcCtD
Carvedilol—Nervousness—Pamidronate—Paget's disease of bone	0.00171	0.00221	CcSEcCtD
Carvedilol—Back pain—Pamidronate—Paget's disease of bone	0.0017	0.0022	CcSEcCtD
Carvedilol—VEGFA—Cellular responses to stress—VCP—Paget's disease of bone	0.00169	0.00748	CbGpPWpGaD
Carvedilol—Muscle spasms—Pamidronate—Paget's disease of bone	0.00169	0.00218	CcSEcCtD
Carvedilol—Angioedema—Risedronate—Paget's disease of bone	0.00169	0.00218	CcSEcCtD
Carvedilol—Angiopathy—Zoledronate—Paget's disease of bone	0.00167	0.00216	CcSEcCtD
Carvedilol—Immune system disorder—Zoledronate—Paget's disease of bone	0.00167	0.00215	CcSEcCtD
Carvedilol—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00166	0.00215	CcSEcCtD
Carvedilol—Vertigo—Risedronate—Paget's disease of bone	0.00166	0.00215	CcSEcCtD
Carvedilol—Syncope—Risedronate—Paget's disease of bone	0.00166	0.00214	CcSEcCtD
Carvedilol—Dyspepsia—Alendronate—Paget's disease of bone	0.00166	0.00214	CcSEcCtD
Carvedilol—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00163	0.00211	CcSEcCtD
Carvedilol—Alopecia—Zoledronate—Paget's disease of bone	0.00163	0.00211	CcSEcCtD
Carvedilol—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00163	0.0021	CcSEcCtD
Carvedilol—Loss of consciousness—Risedronate—Paget's disease of bone	0.00163	0.0021	CcSEcCtD
Carvedilol—Anaemia—Pamidronate—Paget's disease of bone	0.00163	0.0021	CcSEcCtD
Carvedilol—Cough—Risedronate—Paget's disease of bone	0.00161	0.00209	CcSEcCtD
Carvedilol—Constipation—Alendronate—Paget's disease of bone	0.00161	0.00208	CcSEcCtD
Carvedilol—Pain—Alendronate—Paget's disease of bone	0.00161	0.00208	CcSEcCtD
Carvedilol—Angioedema—Pamidronate—Paget's disease of bone	0.00161	0.00208	CcSEcCtD
Carvedilol—Malnutrition—Zoledronate—Paget's disease of bone	0.00161	0.00208	CcSEcCtD
Carvedilol—Hypertension—Risedronate—Paget's disease of bone	0.0016	0.00206	CcSEcCtD
Carvedilol—Malaise—Pamidronate—Paget's disease of bone	0.00159	0.00205	CcSEcCtD
Carvedilol—Syncope—Pamidronate—Paget's disease of bone	0.00158	0.00204	CcSEcCtD
Carvedilol—Arthralgia—Risedronate—Paget's disease of bone	0.00157	0.00203	CcSEcCtD
Carvedilol—Chest pain—Risedronate—Paget's disease of bone	0.00157	0.00203	CcSEcCtD
Carvedilol—Myalgia—Risedronate—Paget's disease of bone	0.00157	0.00203	CcSEcCtD
Carvedilol—Leukopenia—Pamidronate—Paget's disease of bone	0.00157	0.00203	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00156	0.00202	CcSEcCtD
Carvedilol—Pruritus—Etidronic acid—Paget's disease of bone	0.00156	0.00202	CcSEcCtD
Carvedilol—Back pain—Zoledronate—Paget's disease of bone	0.00155	0.00201	CcSEcCtD
Carvedilol—Feeling abnormal—Alendronate—Paget's disease of bone	0.00155	0.002	CcSEcCtD
Carvedilol—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00155	0.002	CcSEcCtD
Carvedilol—Muscle spasms—Zoledronate—Paget's disease of bone	0.00154	0.00199	CcSEcCtD
Carvedilol—Dry mouth—Risedronate—Paget's disease of bone	0.00154	0.00199	CcSEcCtD
Carvedilol—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00154	0.00199	CcSEcCtD
Carvedilol—Cough—Pamidronate—Paget's disease of bone	0.00153	0.00198	CcSEcCtD
Carvedilol—Convulsion—Pamidronate—Paget's disease of bone	0.00152	0.00197	CcSEcCtD
Carvedilol—Hypertension—Pamidronate—Paget's disease of bone	0.00152	0.00196	CcSEcCtD
Carvedilol—Vision blurred—Zoledronate—Paget's disease of bone	0.00151	0.00196	CcSEcCtD
Carvedilol—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00151	0.00195	CcSEcCtD
Carvedilol—Infection—Risedronate—Paget's disease of bone	0.0015	0.00194	CcSEcCtD
Carvedilol—Arthralgia—Pamidronate—Paget's disease of bone	0.0015	0.00193	CcSEcCtD
Carvedilol—Myalgia—Pamidronate—Paget's disease of bone	0.0015	0.00193	CcSEcCtD
Carvedilol—Urticaria—Alendronate—Paget's disease of bone	0.00149	0.00193	CcSEcCtD
Carvedilol—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00149	0.00193	CcSEcCtD
Carvedilol—Abdominal pain—Alendronate—Paget's disease of bone	0.00149	0.00192	CcSEcCtD
Carvedilol—Body temperature increased—Alendronate—Paget's disease of bone	0.00149	0.00192	CcSEcCtD
Carvedilol—Shock—Risedronate—Paget's disease of bone	0.00149	0.00192	CcSEcCtD
Carvedilol—Anaemia—Zoledronate—Paget's disease of bone	0.00148	0.00192	CcSEcCtD
Carvedilol—VCAM1—Adaptive Immune System—INPP5D—Paget's disease of bone	0.00148	0.00655	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00148	0.00655	CbGpPWpGaD
Carvedilol—Discomfort—Pamidronate—Paget's disease of bone	0.00148	0.00191	CcSEcCtD
Carvedilol—Angioedema—Zoledronate—Paget's disease of bone	0.00147	0.0019	CcSEcCtD
Carvedilol—Skin disorder—Risedronate—Paget's disease of bone	0.00147	0.00189	CcSEcCtD
Carvedilol—Malaise—Zoledronate—Paget's disease of bone	0.00145	0.00187	CcSEcCtD
Carvedilol—Confusional state—Pamidronate—Paget's disease of bone	0.00145	0.00187	CcSEcCtD
Carvedilol—Vertigo—Zoledronate—Paget's disease of bone	0.00144	0.00186	CcSEcCtD
Carvedilol—Syncope—Zoledronate—Paget's disease of bone	0.00144	0.00186	CcSEcCtD
Carvedilol—Leukopenia—Zoledronate—Paget's disease of bone	0.00144	0.00186	CcSEcCtD
Carvedilol—Oedema—Pamidronate—Paget's disease of bone	0.00143	0.00185	CcSEcCtD
Carvedilol—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00143	0.00185	CcSEcCtD
Carvedilol—Infection—Pamidronate—Paget's disease of bone	0.00143	0.00184	CcSEcCtD
Carvedilol—Palpitations—Zoledronate—Paget's disease of bone	0.00142	0.00183	CcSEcCtD
Carvedilol—Shock—Pamidronate—Paget's disease of bone	0.00141	0.00182	CcSEcCtD
Carvedilol—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00141	0.00182	CcSEcCtD
Carvedilol—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.0014	0.00182	CcSEcCtD
Carvedilol—Vomiting—Etidronic acid—Paget's disease of bone	0.0014	0.00181	CcSEcCtD
Carvedilol—Cough—Zoledronate—Paget's disease of bone	0.0014	0.00181	CcSEcCtD
Carvedilol—Tachycardia—Pamidronate—Paget's disease of bone	0.0014	0.00181	CcSEcCtD
Carvedilol—Rash—Etidronic acid—Paget's disease of bone	0.00139	0.0018	CcSEcCtD
Carvedilol—Convulsion—Zoledronate—Paget's disease of bone	0.00139	0.0018	CcSEcCtD
Carvedilol—Dermatitis—Etidronic acid—Paget's disease of bone	0.00139	0.0018	CcSEcCtD
Carvedilol—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00139	0.00179	CcSEcCtD
Carvedilol—Hypertension—Zoledronate—Paget's disease of bone	0.00139	0.00179	CcSEcCtD
Carvedilol—Hypersensitivity—Alendronate—Paget's disease of bone	0.00139	0.00179	CcSEcCtD
Carvedilol—Headache—Etidronic acid—Paget's disease of bone	0.00138	0.00179	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00138	0.00178	CcSEcCtD
Carvedilol—Anorexia—Pamidronate—Paget's disease of bone	0.00137	0.00177	CcSEcCtD
Carvedilol—Arthralgia—Zoledronate—Paget's disease of bone	0.00137	0.00177	CcSEcCtD
Carvedilol—Myalgia—Zoledronate—Paget's disease of bone	0.00137	0.00177	CcSEcCtD
Carvedilol—Chest pain—Zoledronate—Paget's disease of bone	0.00137	0.00177	CcSEcCtD
Carvedilol—Insomnia—Risedronate—Paget's disease of bone	0.00137	0.00176	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00136	0.00175	CcSEcCtD
Carvedilol—Paraesthesia—Risedronate—Paget's disease of bone	0.00136	0.00175	CcSEcCtD
Carvedilol—Discomfort—Zoledronate—Paget's disease of bone	0.00135	0.00175	CcSEcCtD
Carvedilol—Asthenia—Alendronate—Paget's disease of bone	0.00135	0.00174	CcSEcCtD
Carvedilol—Dyspnoea—Risedronate—Paget's disease of bone	0.00135	0.00174	CcSEcCtD
Carvedilol—Hypotension—Pamidronate—Paget's disease of bone	0.00134	0.00173	CcSEcCtD
Carvedilol—Dry mouth—Zoledronate—Paget's disease of bone	0.00134	0.00173	CcSEcCtD
Carvedilol—Pruritus—Alendronate—Paget's disease of bone	0.00133	0.00172	CcSEcCtD
Carvedilol—Dyspepsia—Risedronate—Paget's disease of bone	0.00133	0.00172	CcSEcCtD
Carvedilol—Confusional state—Zoledronate—Paget's disease of bone	0.00132	0.00171	CcSEcCtD
Carvedilol—Nausea—Etidronic acid—Paget's disease of bone	0.00131	0.00169	CcSEcCtD
Carvedilol—Oedema—Zoledronate—Paget's disease of bone	0.00131	0.00169	CcSEcCtD
Carvedilol—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00131	0.00169	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00131	0.00169	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.0013	0.00168	CcSEcCtD
Carvedilol—Infection—Zoledronate—Paget's disease of bone	0.0013	0.00168	CcSEcCtD
Carvedilol—Fatigue—Risedronate—Paget's disease of bone	0.0013	0.00168	CcSEcCtD
Carvedilol—Insomnia—Pamidronate—Paget's disease of bone	0.0013	0.00168	CcSEcCtD
Carvedilol—Pain—Risedronate—Paget's disease of bone	0.00129	0.00167	CcSEcCtD
Carvedilol—Constipation—Risedronate—Paget's disease of bone	0.00129	0.00167	CcSEcCtD
Carvedilol—Shock—Zoledronate—Paget's disease of bone	0.00129	0.00167	CcSEcCtD
Carvedilol—Paraesthesia—Pamidronate—Paget's disease of bone	0.00129	0.00166	CcSEcCtD
Carvedilol—Diarrhoea—Alendronate—Paget's disease of bone	0.00129	0.00166	CcSEcCtD
Carvedilol—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00128	0.00166	CcSEcCtD
Carvedilol—Dyspnoea—Pamidronate—Paget's disease of bone	0.00128	0.00165	CcSEcCtD
Carvedilol—Tachycardia—Zoledronate—Paget's disease of bone	0.00128	0.00165	CcSEcCtD
Carvedilol—Somnolence—Pamidronate—Paget's disease of bone	0.00128	0.00165	CcSEcCtD
Carvedilol—Skin disorder—Zoledronate—Paget's disease of bone	0.00127	0.00164	CcSEcCtD
Carvedilol—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00127	0.00164	CcSEcCtD
Carvedilol—Dyspepsia—Pamidronate—Paget's disease of bone	0.00126	0.00163	CcSEcCtD
Carvedilol—Anorexia—Zoledronate—Paget's disease of bone	0.00125	0.00161	CcSEcCtD
Carvedilol—Decreased appetite—Pamidronate—Paget's disease of bone	0.00125	0.00161	CcSEcCtD
Carvedilol—Dizziness—Alendronate—Paget's disease of bone	0.00124	0.00161	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00124	0.0016	CcSEcCtD
Carvedilol—Fatigue—Pamidronate—Paget's disease of bone	0.00124	0.0016	CcSEcCtD
Carvedilol—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00123	0.00159	CcSEcCtD
Carvedilol—Constipation—Pamidronate—Paget's disease of bone	0.00123	0.00159	CcSEcCtD
Carvedilol—Pain—Pamidronate—Paget's disease of bone	0.00123	0.00159	CcSEcCtD
Carvedilol—Hypotension—Zoledronate—Paget's disease of bone	0.00122	0.00158	CcSEcCtD
Carvedilol—Urticaria—Risedronate—Paget's disease of bone	0.0012	0.00155	CcSEcCtD
Carvedilol—Vomiting—Alendronate—Paget's disease of bone	0.0012	0.00155	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00119	0.00154	CcSEcCtD
Carvedilol—Abdominal pain—Risedronate—Paget's disease of bone	0.00119	0.00154	CcSEcCtD
Carvedilol—Body temperature increased—Risedronate—Paget's disease of bone	0.00119	0.00154	CcSEcCtD
Carvedilol—Rash—Alendronate—Paget's disease of bone	0.00119	0.00153	CcSEcCtD
Carvedilol—Insomnia—Zoledronate—Paget's disease of bone	0.00119	0.00153	CcSEcCtD
Carvedilol—Dermatitis—Alendronate—Paget's disease of bone	0.00119	0.00153	CcSEcCtD
Carvedilol—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00118	0.00153	CcSEcCtD
Carvedilol—Headache—Alendronate—Paget's disease of bone	0.00118	0.00152	CcSEcCtD
Carvedilol—Paraesthesia—Zoledronate—Paget's disease of bone	0.00118	0.00152	CcSEcCtD
Carvedilol—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00117	0.00152	CcSEcCtD
Carvedilol—Dyspnoea—Zoledronate—Paget's disease of bone	0.00117	0.00151	CcSEcCtD
Carvedilol—Somnolence—Zoledronate—Paget's disease of bone	0.00117	0.00151	CcSEcCtD
Carvedilol—Dyspepsia—Zoledronate—Paget's disease of bone	0.00115	0.00149	CcSEcCtD
Carvedilol—Decreased appetite—Zoledronate—Paget's disease of bone	0.00114	0.00147	CcSEcCtD
Carvedilol—Abdominal pain—Pamidronate—Paget's disease of bone	0.00113	0.00147	CcSEcCtD
Carvedilol—Body temperature increased—Pamidronate—Paget's disease of bone	0.00113	0.00147	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00113	0.00146	CcSEcCtD
Carvedilol—Fatigue—Zoledronate—Paget's disease of bone	0.00113	0.00146	CcSEcCtD
Carvedilol—HIF1A—Disease—VCP—Paget's disease of bone	0.00113	0.00499	CbGpPWpGaD
Carvedilol—Pain—Zoledronate—Paget's disease of bone	0.00112	0.00145	CcSEcCtD
Carvedilol—Constipation—Zoledronate—Paget's disease of bone	0.00112	0.00145	CcSEcCtD
Carvedilol—Nausea—Alendronate—Paget's disease of bone	0.00112	0.00144	CcSEcCtD
Carvedilol—Hypersensitivity—Risedronate—Paget's disease of bone	0.00111	0.00144	CcSEcCtD
Carvedilol—Asthenia—Risedronate—Paget's disease of bone	0.00108	0.0014	CcSEcCtD
Carvedilol—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00108	0.0014	CcSEcCtD
Carvedilol—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00107	0.00138	CcSEcCtD
Carvedilol—Pruritus—Risedronate—Paget's disease of bone	0.00107	0.00138	CcSEcCtD
Carvedilol—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00106	0.00137	CcSEcCtD
Carvedilol—VCAM1—Immune System—NUP205—Paget's disease of bone	0.00105	0.00466	CbGpPWpGaD
Carvedilol—ADRB1—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00105	0.00462	CbGpPWpGaD
Carvedilol—Urticaria—Zoledronate—Paget's disease of bone	0.00104	0.00135	CcSEcCtD
Carvedilol—Abdominal pain—Zoledronate—Paget's disease of bone	0.00104	0.00134	CcSEcCtD
Carvedilol—Body temperature increased—Zoledronate—Paget's disease of bone	0.00104	0.00134	CcSEcCtD
Carvedilol—Diarrhoea—Risedronate—Paget's disease of bone	0.00103	0.00133	CcSEcCtD
Carvedilol—Asthenia—Pamidronate—Paget's disease of bone	0.00103	0.00133	CcSEcCtD
Carvedilol—ADRB2—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00102	0.00452	CbGpPWpGaD
Carvedilol—Pruritus—Pamidronate—Paget's disease of bone	0.00102	0.00131	CcSEcCtD
Carvedilol—Dizziness—Risedronate—Paget's disease of bone	0.000998	0.00129	CcSEcCtD
Carvedilol—Diarrhoea—Pamidronate—Paget's disease of bone	0.000982	0.00127	CcSEcCtD
Carvedilol—Hypersensitivity—Zoledronate—Paget's disease of bone	0.000966	0.00125	CcSEcCtD
Carvedilol—Vomiting—Risedronate—Paget's disease of bone	0.00096	0.00124	CcSEcCtD
Carvedilol—Rash—Risedronate—Paget's disease of bone	0.000952	0.00123	CcSEcCtD
Carvedilol—Dermatitis—Risedronate—Paget's disease of bone	0.000951	0.00123	CcSEcCtD
Carvedilol—Dizziness—Pamidronate—Paget's disease of bone	0.000949	0.00123	CcSEcCtD
Carvedilol—Headache—Risedronate—Paget's disease of bone	0.000946	0.00122	CcSEcCtD
Carvedilol—Asthenia—Zoledronate—Paget's disease of bone	0.00094	0.00122	CcSEcCtD
Carvedilol—NDUFC2—Metabolism—NUP205—Paget's disease of bone	0.000936	0.00414	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—PML—Paget's disease of bone	0.000931	0.00412	CbGpPWpGaD
Carvedilol—Pruritus—Zoledronate—Paget's disease of bone	0.000927	0.0012	CcSEcCtD
Carvedilol—Vomiting—Pamidronate—Paget's disease of bone	0.000912	0.00118	CcSEcCtD
Carvedilol—Rash—Pamidronate—Paget's disease of bone	0.000905	0.00117	CcSEcCtD
Carvedilol—Dermatitis—Pamidronate—Paget's disease of bone	0.000904	0.00117	CcSEcCtD
Carvedilol—Headache—Pamidronate—Paget's disease of bone	0.000899	0.00116	CcSEcCtD
Carvedilol—VCAM1—Immune System—INPP5D—Paget's disease of bone	0.000898	0.00397	CbGpPWpGaD
Carvedilol—Diarrhoea—Zoledronate—Paget's disease of bone	0.000897	0.00116	CcSEcCtD
Carvedilol—Nausea—Risedronate—Paget's disease of bone	0.000897	0.00116	CcSEcCtD
Carvedilol—Dizziness—Zoledronate—Paget's disease of bone	0.000867	0.00112	CcSEcCtD
Carvedilol—HIF1A—Disease—NUP205—Paget's disease of bone	0.000862	0.00381	CbGpPWpGaD
Carvedilol—Nausea—Pamidronate—Paget's disease of bone	0.000852	0.0011	CcSEcCtD
Carvedilol—Vomiting—Zoledronate—Paget's disease of bone	0.000833	0.00108	CcSEcCtD
Carvedilol—Rash—Zoledronate—Paget's disease of bone	0.000826	0.00107	CcSEcCtD
Carvedilol—Dermatitis—Zoledronate—Paget's disease of bone	0.000826	0.00107	CcSEcCtD
Carvedilol—Headache—Zoledronate—Paget's disease of bone	0.000821	0.00106	CcSEcCtD
Carvedilol—VCAM1—Immune System—SQSTM1—Paget's disease of bone	0.000805	0.00356	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—INPP5D—Paget's disease of bone	0.000799	0.00353	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—VCP—Paget's disease of bone	0.00079	0.00349	CbGpPWpGaD
Carvedilol—Nausea—Zoledronate—Paget's disease of bone	0.000779	0.00101	CcSEcCtD
Carvedilol—VEGFA—Hemostasis—INPP5D—Paget's disease of bone	0.000655	0.0029	CbGpPWpGaD
Carvedilol—HIF1A—Disease—CALCA—Paget's disease of bone	0.00064	0.00283	CbGpPWpGaD
Carvedilol—ADRB3—GPCR ligand binding—CALCA—Paget's disease of bone	0.000639	0.00283	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000461	0.00204	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000458	0.00203	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—CALCA—Paget's disease of bone	0.000448	0.00198	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—CALCA—Paget's disease of bone	0.000416	0.00184	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—INPP5D—Paget's disease of bone	0.000386	0.00171	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—CALCA—Paget's disease of bone	0.000379	0.00168	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—CALCA—Paget's disease of bone	0.000376	0.00166	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—CALCA—Paget's disease of bone	0.000371	0.00164	CbGpPWpGaD
Carvedilol—XDH—Metabolism—NUP205—Paget's disease of bone	0.000366	0.00162	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000361	0.0016	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—INPP5D—Paget's disease of bone	0.000361	0.0016	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—CALCA—Paget's disease of bone	0.000351	0.00155	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—CALCA—Paget's disease of bone	0.000346	0.00153	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—VCP—Paget's disease of bone	0.000342	0.00151	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—VCP—Paget's disease of bone	0.000341	0.00151	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—CALCA—Paget's disease of bone	0.000328	0.00145	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000328	0.00145	CbGpPWpGaD
Carvedilol—XDH—Metabolism—INPP5D—Paget's disease of bone	0.000312	0.00138	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—CALCA—Paget's disease of bone	0.000307	0.00136	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—INPP5D—Paget's disease of bone	0.000293	0.0013	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—CALCA—Paget's disease of bone	0.000285	0.00126	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000235	0.00104	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000231	0.00102	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—VCP—Paget's disease of bone	0.000223	0.000984	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000214	0.000949	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—CALCA—Paget's disease of bone	0.000214	0.000945	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000212	0.00094	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—CALCA—Paget's disease of bone	0.00021	0.000928	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000206	0.00091	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—VCP—Paget's disease of bone	0.000203	0.000897	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—VCP—Paget's disease of bone	0.000201	0.000889	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—SQSTM1—Paget's disease of bone	0.0002	0.000883	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000199	0.000881	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000198	0.000878	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—VCP—Paget's disease of bone	0.000198	0.000877	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000195	0.000864	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CALCA—Paget's disease of bone	0.000195	0.000861	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CALCA—Paget's disease of bone	0.000194	0.000857	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CALCA—Paget's disease of bone	0.000193	0.000855	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CALCA—Paget's disease of bone	0.000193	0.000853	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CALCA—Paget's disease of bone	0.00019	0.000843	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—VCP—Paget's disease of bone	0.000188	0.00083	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—VCP—Paget's disease of bone	0.000185	0.000817	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CALCA—Paget's disease of bone	0.00018	0.000797	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CALCA—Paget's disease of bone	0.000177	0.000785	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000173	0.000767	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000172	0.000762	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—NUP205—Paget's disease of bone	0.000172	0.000759	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—NUP205—Paget's disease of bone	0.000171	0.000757	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—VCP—Paget's disease of bone	0.000164	0.000726	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000161	0.000713	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CALCA—Paget's disease of bone	0.000158	0.000697	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—VCP—Paget's disease of bone	0.000152	0.000674	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000147	0.000651	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CALCA—Paget's disease of bone	0.000146	0.000648	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—INPP5D—Paget's disease of bone	0.000146	0.000647	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—INPP5D—Paget's disease of bone	0.000146	0.000646	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—NUP205—Paget's disease of bone	0.000139	0.000616	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00013	0.000575	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NUP205—Paget's disease of bone	0.000128	0.000566	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CALCA—Paget's disease of bone	0.000126	0.000558	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NUP205—Paget's disease of bone	0.000121	0.000534	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—INPP5D—Paget's disease of bone	0.000119	0.000526	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000118	0.000524	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000117	0.000519	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000116	0.000513	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CALCA—Paget's disease of bone	0.000115	0.000509	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CALCA—Paget's disease of bone	0.000114	0.000504	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CALCA—Paget's disease of bone	0.000113	0.000498	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00011	0.000485	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—INPP5D—Paget's disease of bone	0.000109	0.000483	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000108	0.000477	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CALCA—Paget's disease of bone	0.000106	0.000471	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CALCA—Paget's disease of bone	0.000105	0.000464	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—INPP5D—Paget's disease of bone	0.000103	0.000455	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NUP205—Paget's disease of bone	9.63e-05	0.000426	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SQSTM1—Paget's disease of bone	9.58e-05	0.000424	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CALCA—Paget's disease of bone	9.31e-05	0.000412	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NUP205—Paget's disease of bone	9.08e-05	0.000402	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NUP205—Paget's disease of bone	9e-05	0.000398	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SQSTM1—Paget's disease of bone	8.9e-05	0.000394	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CALCA—Paget's disease of bone	8.65e-05	0.000383	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—INPP5D—Paget's disease of bone	8.21e-05	0.000363	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—INPP5D—Paget's disease of bone	7.74e-05	0.000342	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NUP205—Paget's disease of bone	7.69e-05	0.00034	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—INPP5D—Paget's disease of bone	7.67e-05	0.000339	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—INPP5D—Paget's disease of bone	6.56e-05	0.00029	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NUP205—Paget's disease of bone	5.94e-05	0.000263	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	5.06e-05	0.000224	CbGpPWpGaD
